For example, in 1997, a group of scientists demonstrated that sorbitol elevation in cells could confer resistance to NSCLC cells against Cisplatin, suggesting that an increased activity of AKR1B1, which produces sorbitol, may have the same outcome.91 The gene discussed is AKR1B1; the disease is non-small cell lung carcinoma.